Author:
Gül Fethi,Kasapoğlu Umut Sabri,Sabaz Mehmet Süleyman,Ay Pınar,Doruk Oktay Burçin,Çalışkan Gülbahar,Demir Nalan,Sayan İsmet,Kabadayı Feyyaz,Altuntaş Gülsüm,Gümüş Ayça,Kırca Hülya,Şanlı Deniz,Acil Fatma,Dedeoğlu Andaç,Ural Sedef Gülçin,Akın Şen İrem,Macit Aydın Eda,Dayanır Hakan,Yelken Birgül,Ceylan İlkay,Aydın Osman Özcan,Eskidemir Güneş,Aytekin Ahmet,Cengiz Melike,Arslan Ülkü,Akdağ Devrim,Alay Gülçin Hilal,Tekin Esra,Yarar Volkan,Saracoğlu Kemal Tolga,Gök Funda,Alparslan Volkan,Tuna Verda,Yıldız Murside,Şenoğlu Nimet,Kıraklı Cenk,Yıldırım Süleyman,Saçar Kübüç Kübra,Erer Ayşen,Gültekin Hamza,Özmen Süner Kezban,Kuzgun Özge,Öztürk Çağatay Erman,Karahan Aydın,Deveci Okan,Ay Mustafa,Tüfek Öztan Dilara,Akıncı Seda Banu
Reference40 articles.
1. 1. Richardson S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020;323:2052-2059. [CrossRef]
2. 2. Grasselli G, Zangrillo A, Zanella A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323:1574-1581. [CrossRef]
3. 3. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-1062. [CrossRef]
4. 4. Dallmeier K, Meyfroidt G, Neyts J. COVID-19 and the intensive care unit: vaccines to the rescue. Intensive Care Med. 2021;47:786-789. [CrossRef]
5. 5. Odabasi Z, Cinel I. Consideration of Severe Coronavirus Disease 2019 As Viral Sepsis and Potential Use of Immune Checkpoint Inhibitors. Crit Care Explor. 2020;2:e0141. [CrossRef]